Navigation Links
ImaRx Therapeutics Receives Notification from NASDAQ Regarding Non-Compliance with NASDAQ's Minimum Bid Price Requirement
Date:4/11/2008

TUCSON, Ariz., April 11 /PRNewswire-FirstCall/ -- ImaRx Therapeutics, Inc. (Nasdaq: IMRX) today announced that it received a NASDAQ Staff Deficiency Letter on April 11, 2008 indicating that for the last 30 consecutive business days, the bid price of its common stock has closed below $1.00 per share. As a result, the company fails to comply with the minimum bid price requirement for continued listing set forth in Marketplace Rule 4310(c)(4).

In accordance with Marketplace Rule 4310(c)(8)(D), the company has been provided 180 calendar days, or until October 8, 2008, to regain compliance. The company will achieve compliance, if before October 8, 2008, the bid price of the company's common stock closes at $1.00 per share or more for a minimum of 10 consecutive business days. If the company does not regain compliance by October 8, 2008, but can demonstrate as of that date that the Company meets the criteria for initial listing set forth in Marketplace Rule 4310(c) (other than the bid price requirement) and its application is approved, the Company will have an additional 180 days to regain compliance.

The Company intends to monitor the closing bid price of its common stock between now and October 8, 2008, and work closely with NASDAQ to resolve the deficiency and consider available options to regain compliance with the NASDAQ minimum closing bid price requirement.

About ImaRx Therapeutics

ImaRx Therapeutics is a biopharmaceutical company commercializing and developing therapies for vascular disorders. The Company's commercialization efforts are currently focused on its product, urokinase for the treatment of acute massive pulmonary embolism. The Company's research and development efforts are focused on therapies for
'/>"/>

SOURCE ImaRx Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007
2. ImaRx Reschedules Release of Corporate Updates and Fourth Quarter and Full Year 2007 Financial Results
3. ImaRx to Report Corporate Updates and 4Q07 Financial Results
4. ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
5. CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection
6. Stemline Therapeutics Raises $12.5 Million
7. Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
8. Amsterdam Molecular Therapeutics Part of Next Biotech Index
9. Sirion Therapeutics Highlights Pivotal Trial Results of Durezol(TM) at the American Society of Cataract and Refractive Surgery Annual Symposium
10. Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer
11. Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2008)...ADELPHIA, Dec. 3 GlaxoSm...it is waiving a condition relating to a,pending l... purchase all of,the outstanding shares of common...GNLB ), for $1.30 per share in cash without intere... It is a condition to the completion of the ten...
(Date:12/3/2008)...c. 3 CeloNova BioSciences, Inc., a...which it is commercializing the,CATANIA(TM) Coron...stent,system that has not had any stent thrombosi...ble for purchase throughout Europe and now some Mi... expansion ongoing. Concurrently,CeloNova notes ...
(Date:12/3/2008)... A key element of Carpenter,s EnviroStep...de; Active Layer RS moisture barrier film is lamin...spills or liquids from soaking in. , ...8 -- DuPont today announced it has introduced DuP...ture barrier films for use in carpet cushioning. ,...
(Date:12/3/2008)... Dennis will Outline How Technology Can Solve Pres..., , , KINGSTON, ON, Dec. 3 /PRNewswire/ - D...nc. (PPI), is one of four leading experts speaking...nge Conference underway in Poznan , Poland. Dr. De...blems in the 20th Century and the role it will pla...
Breaking Biology Technology:GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 2GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 3CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 2CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 3DuPont Launches Innovative Renewably Sourced Material for Carpet Cushion 2DuPont Launches Innovative Renewably Sourced Material for Carpet Cushion 3DuPont Launches Innovative Renewably Sourced Material for Carpet Cushion 4Leading Canadian Scientist to speak at UN Climate Change Conference 2
..., , , , , , , Vincent ... Brinkmann Instruments Inc., Westbury, New York ,... Perhaps the most critical parameter for successf...gs being equal, a poorly designed , primer ...he primer sequence , determines several thi...
...wo-dimensional Optimization of a Semi-nested PCR ,... , , , , , , Andrea Ta... Institute of Milk Hygiene, Milk Technology and Fo...hrer, Eppendorf AG, Germany, , , , ,...teritides, which are triggered by contaminated foo...
..., , , , , , , Problems ...fragment using the PCR* are an everyday occurrence...ndary bands may form after the PCR reaction, which...s (cycle sequencing, mutation detection, , ...lt. In such cases, PCR , conditions must be...
..., , , , , , , Ravindra...ity Medicine, Universiti Malaysia Sarawak , ...imization of annealing temperature , for De...ient , , Reverse Transcriptase-Po..., often carried out at the Institute of Healt...
Other Biology Technology:General Notes on Primer Design in PCR* 2General Notes on Primer Design in PCR* 3General Notes on Primer Design in PCR* 4General Notes on Primer Design in PCR* 5General Notes on Primer Design in PCR* 6Two-dimensional Optimization of a Semi-nested PCR, for Detecting Listeria monocytogenes 2Two-dimensional Optimization of a Semi-nested PCR, for Detecting Listeria monocytogenes 3Two-dimensional Optimization of a Semi-nested PCR, for Detecting Listeria monocytogenes 4Two-dimensional Optimization of a Semi-nested PCR, for Detecting Listeria monocytogenes 5Two-dimensional Optimization of a Semi-nested PCR, for Detecting Listeria monocytogenes 6Two-dimensional Optimization of a Semi-nested PCR, for Detecting Listeria monocytogenes 7Using Gradient PCR to determine the optimum annealing temperature. 2Optimized Dengue RT-PCR 2Optimized Dengue RT-PCR 3
(Date:12/3/2008)...ORTLAND, Ore. December 3, 2008. The first 5-year f...blic lands is now available to the public: Oregon,...ventory and Analysis Report. , Here are some key...span about 30 million acres; about half of Oregon,...and is being converted to other uses particularly ...
(Date:12/3/2008)...ISON, WI, DECEMBER 1, 2008 -- As the United States...nd push towards energy independence, cellulosic-ba...ially viable technologies. Corn stover remains the...il organic carbon (SOC) associated with the remova... is of agricultural and environmental concern. ,...
(Date:12/3/2008)...ed on the outstanding success of the first tandem ...as paired the two satellites together again to hel...-2, ESA,s veteran spacecraft, and Envisat, the lar...y Synthetic Aperture Radar (SAR) instruments that ...ace. ,By combining two or more SAR images of th...
(Date:12/3/2008)...desonide sprays can be regarded as safe for pregna...died though , Women can usually keep using the... pregnant. Budesonide sprays are the best studied ...essential medicines are necessary however. Accordi...ncy in Health Care (IQWiG), more data from trials ...
Breaking Biology News(10 mins):Forest inventories in Oregon include more than trees 2Forest inventories in Oregon include more than trees 3Managing carbon loss 2ESA satellites flying in formation 2Pregnant women with asthma can be more confident about some medicines 2NSF awards 241 5M for study of in home health care via wireless networks 17663 1NSF awards 241 5M for study of in home health care via wireless networks 17663 2NSF awards 241 5M for study of in home health care via wireless networks 17663 3Social Status Plays Role in Brains Control of Health 17662 1Social Status Plays Role in Brains Control of Health 17662 2SEIU RN Dian Palmer Calls on AFL CIO Head John Sweeney to Review Video From Dearborn Protest Retract Statement Accepting CNA Distortions 17658 1SEIU RN Dian Palmer Calls on AFL CIO Head John Sweeney to Review Video From Dearborn Protest Retract Statement Accepting CNA Distortions 17658 2SEIU RN Dian Palmer Calls on AFL CIO Head John Sweeney to Review Video From Dearborn Protest Retract Statement Accepting CNA Distortions 17658 3Miami Jury Convicts Pharmacy Owner of Medicare Fraud 17654 1Miami Jury Convicts Pharmacy Owner of Medicare Fraud 17654 2
...seasonal affective disorder (SAD), starting treatm...all can reduce the risk of developing depression t...udy in the Oct. 15 issue of Biological Psychiatry,...chiatry, published by Elsevier, a world-leading sc...irst systematic studies that indicate that SAD can...
...nted at the American College of Neuropsychopharmac...pecific gene that is necessary for the development...ord. This research, conducted by Stanford Univers...f Health (NIH), could be critical for future under... possibly the treatment of spinal cord injuries. ...
...ality randomized clinical trials have determined t...e medication, may not have any significant influen...disease or hepatitis B or C liver disease. These ...Gastroenterology. , According to the previous stud...ess properties that protect against various hepato...
...be antibiotics for more than half of children with... strep throat, and used nonrecommended antibiotics...otic prescription, according to a study in the Nov... of the throat) accounts for 6 percent of visits b...tricians, according to background information in t...
Other Biology News:In SAD patients, autumn antidepressants can prevent winter depression 2New study identifies key gene in development of connections between brain and spinal cord 2Children overprescribed antibiotics for sore throat 2
Complete cell culture media with cytokines
These versatile vacuum cups provide flexible sealing lips for products with smooth, curved, or irregular surfaces. ,PFG: Flat cup ,PBG: Bellows cup ,PJG: Short Bellows cup ,PCG: Multiple Bellows cup
Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available.
Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available.
Biology Products: